Prospective, Single-centre, Double-Blind, Randomised, Placebo-controlled Study Evaluating Efficacy of Adalimumab + Methotrextate Compared with Placebo + Methotrexate in Patients with Early Oligoarthritis.
Phase of Trial: Phase II
Latest Information Update: 02 Jul 2015
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Arthritis
- Focus Therapeutic Use
- Acronyms ADEOS
- 02 Jul 2015 Status changed from recruiting to completed United Kingdom Clinical Research Network record.
- 15 Apr 2015 Accrual to date is 91% according to United Kingdom Clinical Research Network record.
- 11 Mar 2015 Planned End Date changed from 24 Dec 2014 to 30 Jun 2015 as reported by United Kingdom Clinical Research Network record.